The Southern African arc is anchored by South Africa's world-class research infr...
Africa Trials
3,515
US Trials
159,433
Gap Ratio
45x
Gini
0.637
Key Finding
The Gini coefficient of 0.637 indicates severe concentration, with most trials confined to a handful of nations.
Regional Comparison
Distribution Analysis
Inequality Profile
Temporal & Structural
Why It Matters
The Southern African arc is anchored by South Africa's world-class research infrastructure — SAMRC, Wits, UCT — but this dominance means that SADC neighbours receive spillover rather than sovereign capacity.
The Evidence 128 words · target 156
In the spatial mapping of African clinical research, does the pattern of southern african research arc reveal structural inequity in African research investment? This cross-sectional audit evaluated 23,873 African and 190,644 United States interventional trials registered on ClinicalTrials.gov through April 2026. Investigators computed the power-law exponent as the primary estimand using registry metadata for each nation. The distribution yielded a Gini coefficient of 0.637 (95% CI 204.25-2166.26), indicating severe concentration of trials among a small number of nations. Shannon entropy of the trial distribution was 1.73 bits, confirming substantial concentration beyond random variation. These findings reveal a geographic research monopoly where most African nations remain functionally invisible in the clinical evidence landscape. Interpretation is constrained by missing sub-national data and the exclusion of observational studies from the analysis.
Sentence Structure
Question
In the spatial mapping of African clinical research, does the pattern of southern african research arc reveal structural inequity in African research investment?
Dataset
This cross-sectional audit evaluated 23,873 African and 190,644 United States interventional trials registered on ClinicalTrials.
Method
gov through April 2026.
Primary Result
Investigators computed the power-law exponent as the primary estimand using registry metadata for each nation.
Robustness
The distribution yielded a Gini coefficient of 0.
Interpretation
637 (95% CI 204.
Boundary
25-2166.
Extra
26), indicating severe concentration of trials among a small number of nations.
Extra
Shannon entropy of the trial distribution was 1.
Extra
73 bits, confirming substantial concentration beyond random variation.
Extra
These findings reveal a geographic research monopoly where most African nations remain functionally invisible in the clinical evidence landscape.
Extra
Interpretation is constrained by missing sub-national data and the exclusion of observational studies from the analysis.